Want to join the conversation?
For $MYL's Generics segment, sales in Rest of World region were just under $550MM, a YoverY growth of 47% on constant currency basis. Legacy business sales grew 21% on constant currency basis, driven by new product launches in Australia and Japan and higher volumes from India operations, especially ARV franchise, and promising business in Brazil.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.